Built for Better Decisions in Complex Markets
Due Diligence
Process
ACA Pharma helps partners launch high-potential medicines and devices through a rigorous, execution-focused due diligence process. By combining product strategy, market intelligence, & commercialization planning, we execute rapid paths to market across Greater China, Southeast Asia & other key growth regions.
Learn More
Product Strategy, Go-to-Market & Strategic Partnerships
Our core competencies include the development of practical product strategies, the design of complete go-to-market plans and the evaluation of strategic partnership opportunities. We bring together deep sector knowledge, commercial insight, and hands-on experience to deliver tailored analysis that reflects each client’s specific goals and market context. This approach allows us to provide thoughtful, execution-oriented guidance that supports better decisions and stronger outcomes.
Where Medical Insight Meets Market Intelligence
We are backed by a powerful foundation of medical intelligence, business information, and proprietary data resources, comprising hundreds of millions of data points. Our capabilities include access to more than 150 leading pharmaceutical business databases, millions of detailed company profiles and news sources, and over 2,000 internally generated intelligence resources. This depth and breadth of information enables us to rapidly develop a clear, nuanced understanding of market dynamics, competitive landscapes, and potential partnership opportunities.
Asia Market Entry Specialists
On-the-ground execution, broader reach
We support rare-disease programs across therapeutic areas, from early access to multi-country expansion beyond China
